Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction
about
The Brugada Syndrome: A Rare Arrhythmia Disorder with Complex InheritanceGenome-wide association studies of late-onset cardiovascular diseaseEpidemiology and genetics of ventricular fibrillation during acute myocardial infarction2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theCoxsackie and adenovirus receptor is a modifier of cardiac conduction and arrhythmia vulnerability in the setting of myocardial ischemiaGenetics of sudden cardiac death syndromesGenetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS studyGenome-wide association of implantable cardioverter-defibrillator activation with life-threatening arrhythmiasSudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop.The relationship between J wave on the surface electrocardiography and ventricular fibrillation during acute myocardial infarction.Genome-wide identification of expression quantitative trait loci (eQTLs) in human heartRisk stratification for sudden cardiac death: current status and challenges for the futureIdentification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals.Genetic, clinical and pharmacological determinants of out-of-hospital cardiac arrest: rationale and outline of the AmsteRdam Resuscitation Studies (ARREST) registryEpilepsy is a risk factor for sudden cardiac arrest in the general population.The quest for the identification of genetic variants in unexplained cardiac arrest and idiopathic ventricular fibrillation.Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease.Personalized medicine and the genotype-phenotype dilemma.Prediction of sudden cardiac death: next steps in pursuit of effective methodology.Common variants in CASQ2, GPD1L, and NOS1AP are significantly associated with risk of sudden death in patients with coronary artery disease.Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarizationCumulative effects of common genetic variants on risk of sudden cardiac death.Epidemiology and genetics of sudden cardiac deathHeritability of Risk for Sudden Cardiac Arrest in ESRD.A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial InfarctionThe genetics of sudden cardiac death.Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging.Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant.Variants in CXADR and F2RL1 are associated with blood pressure and obesity in African-Americans in regions identified through admixture mapping.SNPs identified as modulators of ECG traits in the general population do not markedly affect ECG traits during acute myocardial infarction nor ventricular fibrillation risk in this condition.A common missense variant in the neuregulin 1 gene is associated with both schizophrenia and sudden cardiac death.The spectrum of epidemiology underlying sudden cardiac death.Systems biology and cardiac arrhythmiasSudden unexpected death in epilepsy genetics: Molecular diagnostics and preventionEmerging genomic applications in coronary artery disease.Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?Genetic etiology and evaluation of sudden cardiac death.Genetics of sudden cardiac death caused by ventricular arrhythmias.Personalized medicine to treat arrhythmias.Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.
P2860
Q26747227-98463366-C989-4A68-BB20-74FCD53149A7Q27012711-10E3BAA1-38FF-4072-BB49-B71148EF42B6Q28072276-1DB8D489-C916-4077-BF1C-7EF70F84D0FCQ28087002-D0F43A22-C4D1-4DB7-8876-98F0125BD5AEQ28303059-71FB36FD-4713-4865-B5C5-8B4E582C93ADQ28307856-64F4B316-4F77-4775-814D-E921199DC397Q28308184-C12BDB76-7F80-4295-A376-3630F0EE3138Q28732889-D1316D41-9F33-4857-9F8E-683A32531180Q30433543-283DA9CC-07AE-461D-A0A5-7A3FDF59F73FQ33627599-4A3A73D5-53CE-4E06-82C8-6F216A465CE1Q33638413-8A78B852-4F37-4E61-B900-72FA63EADF54Q33827123-B0283F77-8A54-4D31-86A2-D83502E42D74Q33954488-81EE0C32-EC95-4FFF-850A-62FA72CBAD19Q34304828-29DC33D7-01C1-49D8-9476-935D419DC1CBQ34391007-A660F5AB-431B-43B7-9500-DDCE0F0D14BDQ34672082-EF992A36-831C-4D56-AEEA-F91EFBBF5E78Q34672534-97405FA1-EF3F-47CC-8E2F-4D28701B496AQ35068864-9BB0E01F-086D-4548-8FAE-220B0B2C9B95Q35122646-77BBAE81-C047-4B09-B685-FE2BF2E6E200Q35177170-A4C3461D-8A88-47C1-AB4C-D1911ECAE24FQ35243435-D10411ED-7CF1-4032-96B4-B8112B4E709AQ35766794-095B48BE-E30E-4334-ABDC-F40D6418C489Q36102464-868639F5-578A-4C37-8DCB-69ADCED7796FQ36223335-44B463BD-9274-494C-BDFE-17C0AC525BFAQ36249059-27A5341D-5E25-4E78-BC6D-7CC3B7D181F6Q36410191-CEE8086E-2620-4462-8EB5-71EAA2C5AEBDQ36549998-4820B50B-3BB4-4DAE-A704-3C0C6A15EE7CQ36593290-E2B83271-D497-4928-BA3A-10FCE9AF1117Q36619369-F7735603-1D1D-4255-958A-D84FB76D7640Q36624759-B29BB5BF-4E8F-4E62-A68A-6168EF2B635AQ36954999-32D61E97-EBB3-4B39-8852-09BBDD5F8018Q37057557-311F5129-9EC4-4E91-A09A-FAEFA63F766EQ37100421-F3E38AA3-BE71-4474-ABEA-8C45B872D731Q37279519-65DE90E3-82CC-4815-A951-B3094878E544Q37877334-72214C18-D161-48F4-8D77-E2EEC08106B5Q38104209-471B197A-F322-4BAE-B41A-F40B7BC93071Q38118161-3549FD41-CBAE-451F-8E7E-F99E3E0BFE4DQ38169914-EBC015CB-09FB-4E1C-A482-8485B95B2A95Q38203726-E161B8AA-7E20-4FDA-B678-6A5D2B2DD6D8Q38244795-362575BD-C218-49D2-A3DB-181F7E13D17F
P2860
Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Genome-wide association study ...... in acute myocardial infarction
@ast
Genome-wide association study ...... in acute myocardial infarction
@en
Genome-wide association study ...... in acute myocardial infarction
@nl
type
label
Genome-wide association study ...... in acute myocardial infarction
@ast
Genome-wide association study ...... in acute myocardial infarction
@en
Genome-wide association study ...... in acute myocardial infarction
@nl
prefLabel
Genome-wide association study ...... in acute myocardial infarction
@ast
Genome-wide association study ...... in acute myocardial infarction
@en
Genome-wide association study ...... in acute myocardial infarction
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Genome-wide association study ...... in acute myocardial infarction
@en
P2093
Abdennasser Bardai
Connie R Bezzina
Dan M Roden
Hanno L Tan
J Wouter Jukema
Jonas S S G de Jong
Lukas R C Dekker
Marieke T Blom
Michael W T Tanck
Nanette H Bishopric
P2860
P2888
P304
P3181
P356
10.1038/NG.623
P407
P50
P577
2010-08-01T00:00:00Z